corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8901

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Douville AW.
Drug industry
New Physician 1971 Mar; 20:139-145


Abstract:

Prices and profits in the drug industry, advertising and drug information, and drug prices in relation to the health care system were reviewed. Compared to other industries during a recent 10-year period, the drug industry is a consistently profitable one with concentration of the market structure in a relatively few companies. Drug prices are administered often without any relationship to cost or to supply and demand. Monopolistic practices, some sanctioned by law, such as patent rights for the encouragement of innovation, others created by advertising and promotional techniques, increase the prices of drugs. Developments in the health care field which may force the drug industry to compete more on a price basis include prepaid insurance plans, the increasing acceptance of generic prescribing through formulary systems, and the expansion of governmental regulation and testing of prescription drugs.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963